Robert (Bob) Coradini, is President of Oak Tree Advisors, LLC., an advisory & consulting group for the global Healthcare & Biotech industry. He has done work with a number of companies that are either leaders in their field or developers of promising technology. Mr. Coradini has over 20 years experience in the health care industry, leading and managing businesses for Johnson & Johnson and GE Medical Systems (GE Healthcare) and recently served as interim CEO and Chairman of MELA Sciences.

Mr. Coradini was a former President of several Johnson & Johnson Companies, including Lifescan, Cordis Endovascular and Cardiovations, President of New Ventures for the J&J Consumer Group, and head of business development for J&J Medical Device & Diagnostics Group. He also ran OrthoNeutrogena and Colbar LifeSciences for J&J while being President of New Ventures of the Johnson & Johnson Consumer Group of Companies. Recently, the OrthoNeutrogena division was acquired by Valeant International.

Prior to J&J, Mr. Coradini was with General Electric for ten years, seven of which were with GE Medical Systems (GE Healthcare) a leader in diagnostic imaging. Mr. Coradini has also served on the Board of public companies MELA Sciences and WaferGen BioSystems as well as numerous private companies.